Pfizer CentreOne
Address: 235 E. 42nd Street, New York, NY 10017About Us
Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
Backed by Pfizer resources, we’ve been delivering technical expertise, regulatory support and long-term supply for over 40 years. With 35+ sites across six continents, our expansive network allows us to securely and efficiently guide complex compounds from development through commercial manufacture.
For more information, visit www.pfizercentreone.com
Sectors
- Contract Research & Development
- Contract Manufacturing
Categories
- Active Pharmaceutical Ingredients
- Finished Dosage
- Small Molecules
- Small Molecule Synthesis
- Chemical Intermediates
- Steroidal Products
- High Potency API's
- Custom Synthesis
- Sterile Formulations
- Fill & Finish
- Injectables
- Parenterals
- High Potency Formulations
- Hormone based Products
- Antibiotics
- Fermentation
- Bioprocessing
- Large Molecules
- BioPharmaceuticals
- Biologics
- Biotechnology
- Lyophilisation
- Controlled Status Products
Key Contacts
Custom API synthesis / Visit https://www.pfizercentreone.com/contact-us / +1-269-833-2296 (US) (fixed)News
Pfizer inks deal to buy Abzena's new North Carolina manufacturing site
Pfizer has bought a brand new manufacturing facility in Sanford, NC, about 40 miles south of the bustling Research Triangle Park.
The pharma giant inked a deal to acquire Abzena’s manufacturing plant, which boasts “extensive capabilities” for the production of biologics drug substance, the companies announced on Tuesday. While they’re keeping the financial figures under wraps for now, Pfizer said the deal is expected to close this quarter.
Pfizer opens €300 million state-of-the-art drug manufacturing site in Freiburg, Germany
On May 24th 2022, an opening ceremony was held for the opening of Pfizer’s newest production facility in Freiburg, Germany, which has been built with Bristol-Myers Squibb (BMS).
The new high containment (HighCon), state-of-the-art drug manufacturing site has now been completed following a €300 million investment to help offer greater support to our European partners across a range of formulation manufacturing services.
This investment into the existing Freiburg site has now transformed it into a center for the efficient, reliable production and packaging of innovative medicines for the global market.
Pfizer's CDMO unit drives growth at hospital business
Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.
CDMO Pfizer CentreOne launches Enviero™ green-chemistry progesterone API
Pfizer CentreOne today announced the introduction of Enviero™ progesterone into the API marketplace. Enviero progesterone is produced by a first-of-its-kind progesterone synthesis developed by Pfizer that reduces waste, greenhouse gas emissions and use of hazardous solvents. Results include cutting the carbon footprint of the progesterone manufacturing process by more than 70 percent and eliminating the use of metal catalysts. Pfizer CentreOne is a global contract manufacturing organization embedded within Pfizer Inc. and a leading supplier of steroid and hormone APIs and intermediates.
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com